Date of Completion: December 2022 Funder: Himalayan Cataract Project (HCP) Aim: Identify factors that determine eye health care service utilisation in people identified with vision impairment in a Rapid Assessment of Avoidable Blindness (RAAB) survey. Background Around 80% of the causes of vision impairment in Ethiopia are either preventable or curable. These issues need to be addressed by establishing acceptable, accessible, and affordable comprehensive eye care services. Ho

Date of Completion: December 2022 Funder: Himalayan Cataract Project (HCP) Aim: Measure the magnitude and causes of blindness and vision impairment and determine coverage and quality of cataract surgical services. Background Ethiopia has one of the highest burdens of blindness and vision impairment worldwide. However, the only nationwide blindness survey was conducted about 20 years ago in 2005/6. This research project provided representative, population-based estimate of the

Date of Completion: May 2022 Funder: Health Campaign Effectiveness Coalition (HCE) at the Task Force for Global Health, USA, Atlanta Aim: Investigate the operational capacity and readiness of the Primary Health Care (PHC) system of Ethiopia and identify acceptable and feasible strategies to transition and sustainably mainstream Neglected Tropical Diseases (NTDs) campaign interventions into the PHC system. Background Mainstreaming NTD interventions into national health systems

Date of Completion: September 2021 Funder: Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD), funded at The Task Force for Global Health primarily by the Bill & Melinda Gates Foundation, by the UK aid from the British government, and by the United States Agency for International Development through its Neglected Tropical Diseases Program. Aim: Explore the impact of Trachomatous Trichiasis (TT) on common mental disorders such as depression, anxiety an

Date of Start: March 2021 Date of Completion: June 2025 Funder: The National Institute of Health to Francis I. Proctor Foundation for Research in Ophthalmology, San Francisco, California, USA. Aim: Determine whether three additional targeted azithromycin treatments administered to 2-9 years children is more effective than annual community MDA only at achieving complete elimination of trachoma after 3 years. Background Since 2007, the Amhara National Regional State Health Bure

Date of Start : November 2022 Date of Completion: February 2028 Funder: Bill and Melinda Gates Foundation Aim: Develop an enhanced monitoring system for Ethiopia's "Child MDA" program to accelerate trachoma elimination. Background : Ethiopia is implementing more frequent than annual (MFTA) azithromycin mass drug administration (MDA), including an additional ‘child MDA’ for children aged 1–9 years, to accelerate trachoma elimination in persistent districts. However, evidence f